TLR3 and breast cancer: These observations are in-line with our previous studies examining the inhibition of TLR3 signaling with C10 in various other TLR-expressing cancers and the importance of TLR3 signaling modulation as a potential therapeutic target for breast cancer [1, 2, 34].